The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.

NACompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 2, 2017

Study Completion Date

November 30, 2018

Conditions
Pancreatic NeoplasmGastric Neoplasm
Interventions
OTHER

Interventional arm: Early best palliative care

Patients will receive standard oncologic care and will be assigned to early systematic best palliative care. They will meet a member of the palliative care team within 2 weeks after enrolment. Thereafter, they shall be visited by a palliative care team member every 2 weeks until death.

Trial Locations (30)

47014

Palliative Care Clinic IRCCS IRST, Meldola

48022

U.O Oncologia medica, Lugo

Unknown

S. Donato, Arezzo, Arezzo

Centro di Riferimento Oncologico CRO, Aviano

Ospedale degli Infermi,, Biella

Ospedale Businco, Cagliari, Cagliari

Policlinico Universitario, Cagliari, Cagliari

ASL AL, Casale Monferrato, Casale Monferrato

Irst-Cesena, Cesena

Sant'Anna, Como

PO M.Santo, Cosenza, Cosenza

Istituti Ospitalieri, Cremona, Cremona

Sant'Anna, Ferrara, Ferrara

S.Giovanni Di Dio, Firenze, Florence

S.Maria Annunziata,, Florence

E.O. Galliera, Genova

Aulss 12,, Mestre

Istituto Nazionale Tumori, Milano, Milan

Ospedale Sacco, Milano, Milan

S.PAOLO, Milan

IOV, Padua

San Matteo, Pavia

Guglielmo da Saliceto, Piacenza

Arcispedale S. Maria Nuova, Reggio Emilia

Fatebenefratelli,, Roma

SS Trinità,, Sora - Frosinone

Gradinego, Torino

AOP 9, Trapani, Trapani

S. Maria Gruccia, Valdarno, Valdarno

AULSS 12, Venezia, Venezia

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER

NCT01996540 - The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial. | Biotech Hunter | Biotech Hunter